Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Frank T. Wen, Ronald A. Thisted, Donald A. Rowley & Hans Schreiber. (2012) A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth. OncoImmunology 1:2, pages 172-178.
Read now
Read now
Lyubica Dabich, Steve Dahlberg, Robert J. Hartsock, Albert F. Lobuglio, Marcia K. Liepman, Petre N. Grozea, Harmon J. Eyre, James K. Weick, John D. Bonnet, Charles A. Coltman & Richard I. Fisher. (1991) Alternated Versus Syncopated CHOP-PVB: Two Studies for the Treatment of Non-Hodgkin's Lymphoma by the Southwest Oncology Group. Cancer Investigation 9:6, pages 613-620.
Read now
Read now
Articles from other publishers (27)
Anna Myriam Perrone, Camelia Alexandra Coada, Gloria Ravegnini, Antonio De Leo, Giuseppe Damiano, Eugenia De Crescenzo, Marco Tesei, Stella Di Costanzo, Lucia Genovesi, Daniela Rubino, Claudio Zamagni & Pierandrea De Iaco. (2023) Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma. International Journal of Gynecologic Cancer 33:8, pages 1270-1278.
Crossref
Crossref
Nilanjana Mani, Ankita Daiya, Rajdeep Chowdhury, Sudeshna Mukherjee & Shibasish Chowdhury. 2023.
Hiroshi Kagamu. (2022) Current Status of Immune Checkpoint Inhibitors免疫チェックポイント阻害薬の現状. Nihon Kikan Shokudoka Gakkai Kaiho 73:5, pages 303-307.
Crossref
Crossref
Kazuto Nakamura, Yoshikazu Kitahara, Toshio Nishimura, Soichi Yamashita, Keiko Kigure, Ikuro Ito & Tatsuya Kanuma. (2020) Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer. World Journal of Surgical Oncology 18:1.
Crossref
Crossref
Helmut Plett, Olga T. Filippova, Annalisa Garbi, Stefan Kommoss, Mikkel Rosendahl, Carrie Langstraat, Saurabh Phadnis, Mustafa Zelal Muallem, Thaïs Baert, Dennis S. Chi, Giovanni Damiano Aletti, Florin-Andrei Taran, Jan Philipp Ramspott, Oliver Zivanovic, Andreas du Bois, Yukio Sonoda, Ginger Gardner, Alexander Traut, Kara Long Roche & Philipp Harter. (2020) Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study. Gynecologic Oncology 159:2, pages 434-441.
Crossref
Crossref
Lise Lecointre, Michel Velten, Massimo Lodi, Ralph Saadeh, Vincent Lavoué, Lobna Ouldamer, Sofiane Bendifallah, Martin Koskas, Pierre Adrien Bolze, Pierre Collinet, Geoffroy Canlorbe, Cyril Touboul, Cyrille Huchon, Charles Coutant, Emilie Faller, Thomas Boisramé, Justine Gantzer, Demarchi Martin, Jean Jacques Baldauf, Chérif Akladios & Marcos Ballester. (2020) Impact of neoadjuvant chemotherapy cycles on survival of patients with advanced ovarian cancer: A French national multicenter study (FRANCOGYN). European Journal of Obstetrics & Gynecology and Reproductive Biology 245, pages 64-72.
Crossref
Crossref
Andrew Phillips, Sudha Sundar, Kavita Singh, James Nevin, Ahmed Elattar, Sean Kehoe & Janos Balega. (2018) Complete cytoreduction after five or more cycles of neo-adjuvant chemotherapy confers a survival benefit in advanced ovarian cancer. European Journal of Surgical Oncology 44:6, pages 760-765.
Crossref
Crossref
Farimah Beheshti, Seyed Mahdi Hassanian, Majid Khazaei, Mahmoud Hosseini, Soodabeh ShahidSales, Malihe Hasanzadeh, Mina Maftouh, Gordon A. Ferns & Amir Avan. (2018) Genetic variation in the DNA repair pathway as a potential determinant of response to platinum-based chemotherapy in breast cancer. Journal of Cellular Physiology 233:4, pages 2752-2758.
Crossref
Crossref
Natalia L. Komarova & Dominik WodarzNatalia L. Komarova & Dominik Wodarz. 2014. Targeted Cancer Treatment in Silico. Targeted Cancer Treatment in Silico
35
58
.
Tolga Eichhorn, Henry Johannes Greten & Thomas Efferth. (2011) Molecular Determinants of the Response of Tumor Cells to Boswellic Acids. Pharmaceuticals 4:8, pages 1171-1182.
Crossref
Crossref
Thomas Efferth, Florian Herrmann, Ahmed Tahrani & Michael Wink. (2011) Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin. Phytomedicine 18:11, pages 959-969.
Crossref
Crossref
Natalia Komarova. 2010. Multiscale Cancer Modeling. Multiscale Cancer Modeling
339
358
.
Natalia L. Komarova & Dominik Wodarz. (2007) Stochastic modeling of cellular colonies with quiescence: An application to drug resistance in cancer. Theoretical Population Biology 72:4, pages 523-538.
Crossref
Crossref
David J. Stewart. (2007) Mechanisms of resistance to cisplatin and carboplatin. Critical Reviews in Oncology/Hematology 63:1, pages 12-31.
Crossref
Crossref
Manish A. Shah & Gary K. Schwartz. (2006) Cyclin dependent kinases as targets for cancer therapy. Update on Cancer Therapeutics 1:3, pages 311-332.
Crossref
Crossref
Natalia Komarova. (2006) Stochastic modeling of drug resistance in cancer. Journal of Theoretical Biology 239:3, pages 351-366.
Crossref
Crossref
Manish A. Shah & Gary K. Schwartz. 2005.
135
162
.
Manny D. Bacolod, Stewart P. Johnson, Anthony E. Pegg, M. Eileen Dolan, Robert C. Moschel, Nancy S. Bullock, Qingming Fang, O. Michael Colvin, Paul Modrich, Darell D. Bigner & Henry S. Friedman. (2004)
Brain tumor cell lines resistant to
O
6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have
O
6-alkylguanine-DNA alkyltransferase mutations
. Molecular Cancer Therapeutics 3:9, pages 1127-1135.
Crossref
Crossref
Manish A Shah & Gary K Schwartz. 2003.
145
170
.
Manish A. Shah & Gary K. Schwartz. (2000) The relevance of drug sequence in combination chemotherapy. Drug Resistance Updates 3:6, pages 335-356.
Crossref
Crossref
John S. Spratt, John S. Meyer & John A. Spratt. (1996) Rates of growth of human neoplasms: Part II. Journal of Surgical Oncology 61:1, pages 68-83.
Crossref
Crossref
John S. Spratt, John S. Meyer & John A. Spratt. (2006) Rates of growth of human solid neoplasms: Part I. Journal of Surgical Oncology 60:2, pages 137-146.
Crossref
Crossref
David Scott Miller, Nick M. Spirtos, Samuel C. Ballon, Richard S. Cox, Olive M. Soriero & Nelson N. H. Teng. (1992) Critical reassessment of second-look exploratory laparotomy for epithelial ovarian carcinoma. Minimal diagnostic and therapeutic value in patients with persistent cancer. Cancer 69:2, pages 502-510.
Crossref
Crossref
John S. Spratt & Shelley W. Spratt. (1990) Medical and legal implications of screening and follow-up procedures for breast cancer. Cancer 66:S14, pages 1351-1362.
Crossref
Crossref
J. S. Spratt & J. A. Spratt. 1989. Breast Diseases. Breast Diseases
97
110
.
James H. Goldie. 1989. Drug Resistance in Cancer Therapy. Drug Resistance in Cancer Therapy
13
26
.
Beverly A. Teicher & Emil FreiIIIIII. (1988) Development of alkylating agent-resistant human tumor cell lines. Cancer Chemotherapy and Pharmacology 21:4, pages 292-298.
Crossref
Crossref